Immunogenic cell stress and death in the treatment of cancer - Centre de recherche des Cordeliers Access content directly
Journal Articles Seminars in Cell and Developmental Biology Year : 2024

Immunogenic cell stress and death in the treatment of cancer

Abstract

The successful treatment of oncological malignancies which results in long-term disease control or the complete eradication of cancerous cells necessitates the onset of adaptive immune responses targeting tumor-specific antigens. Such desirable anticancer immunity can be triggered via the induction of immunogenic cell death (ICD) of cancer cells, thus converting malignant cells into an in situ vaccine that elicits T cell mediated adaptive immune responses and establishes durable immunological memory. The exploration of ICD for cancer treatment has been subject to extensive research. However, functional heterogeneity among ICD activating therapies in many cases requires specific co-medications to achieve full-blown efficacy. Here, we described the hallmarks of ICD and classify ICD activators into three distinct functional categories namely, according to their mode of action: (i) ICD inducers, which increase the immunogenicity of malignant cells, (ii) ICD sensitizers, which prime cellular circuitries for ICD induction by conventional cytotoxic agents, and (iii) ICD enhancers, which improve the perception of ICD signals by antigen presenting dendritic cells. Altogether, ICD induction, sensitization and enhancement offer the possibility to convert well-established conventional anticancer therapies into immunotherapeutic approaches that activate T cell-mediated anticancer immunity.
Embargoed file
Embargoed file
0 1 25
Year Month Jours
Avant la publication
Monday, September 16, 2024
Embargoed file
Monday, September 16, 2024
Please log in to request access to the document

Dates and versions

hal-04601413 , version 1 (04-06-2024)

Identifiers

Cite

Hui Pan, Peng Liu, Liwei Zhao, Yuhong Pan, Misha Mao, et al.. Immunogenic cell stress and death in the treatment of cancer. Seminars in Cell and Developmental Biology, 2024, 156, pp.11-21. ⟨10.1016/j.semcdb.2023.10.007⟩. ⟨hal-04601413⟩
19 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More